Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group
- PMID: 9731089
- DOI: 10.1056/NEJM199809103391104
Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group
Abstract
Background and methods: In postmenopausal women, the serum concentrations of endogenous sex hormones and vitamin D might influence the risk of hip and vertebral fractures. In a study of a cohort of women 65 years of age or older, we compared the serum hormone concentrations at base line in 133 women who subsequently had hip fractures and 138 women who subsequently had vertebral fractures with those in randomly selected control women from the same cohort. Women who were taking estrogen were excluded. The results were adjusted for age and weight.
Results: The women with undetectable serum estradiol concentrations (<5 pg per milliliter [18 pmol per liter]) had a relative risk of 2.5 for subsequent hip fracture (95 percent confidence interval, 1.4 to 4.6) and subsequent vertebral fracture (95 percent confidence interval, 1.4 to 4.2), as compared with the women with detectable serum estradiol concentrations. Serum concentrations of sex hormone-binding globulin that were 1.0 microg per deciliter (34.7 nmol per liter) or higher were associated with a relative risk of 2.0 for hip fracture (95 percent confidence interval, 1.1 to 3.9) and 2.3 for vertebral fracture (95 percent confidence interval, 1.2 to 4.4). Women with both undetectable serum estradiol concentrations and serum sex hormone-binding globulin concentrations of 1 microg per deciliter or more had a relative risk of 6.9 for hip fracture (95 percent confidence interval, 1.5 to 32.0) and 7.9 for vertebral fracture (95 percent confidence interval, 2.2 to 28.0). For those with low serum 1,25-dihydroxyvitamin D concentrations (< or =23 pg per milliliter [55 pmol per liter]), the risk of hip fracture increased by a factor of 2.1 (95 percent confidence interval, 1.2 to 3.5).
Conclusions: Postmenopausal women with undetectable serum estradiol concentrations and high serum concentrations of sex hormone-binding globulin have an increased risk of hip and vertebral fracture.
Comment in
-
Estrogen and the risk of fracture--new data, new questions.N Engl J Med. 1998 Sep 10;339(11):767-8. doi: 10.1056/NEJM199809103391110. N Engl J Med. 1998. PMID: 9731095 No abstract available.
Similar articles
-
Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS study.J Bone Miner Res. 2000 Sep;15(9):1835-41. doi: 10.1359/jbmr.2000.15.9.1835. J Bone Miner Res. 2000. PMID: 10977003
-
Estrogen and the risk of fracture--new data, new questions.N Engl J Med. 1998 Sep 10;339(11):767-8. doi: 10.1056/NEJM199809103391110. N Engl J Med. 1998. PMID: 9731095 No abstract available.
-
Postmenopausal bilateral oophorectomy is not associated with increased fracture risk in older women.J Bone Miner Res. 2005 May;20(5):741-7. doi: 10.1359/JBMR.041220. Epub 2004 Dec 13. J Bone Miner Res. 2005. PMID: 15824846
-
Estrogen and bone health in men and women.Steroids. 2015 Jul;99(Pt A):11-5. doi: 10.1016/j.steroids.2014.12.010. Epub 2014 Dec 30. Steroids. 2015. PMID: 25555470 Review.
-
Sex hormone-binding globulin and risk of fracture in older adults: systematic review and meta-analysis of observational studies.Osteoporos Int. 2018 Oct;29(10):2171-2180. doi: 10.1007/s00198-018-4600-z. Epub 2018 Jul 24. Osteoporos Int. 2018. PMID: 30043106
Cited by
-
Obstructive Sleep Apnea and Risk for Incident Vertebral and Hip Fracture in Women.J Bone Miner Res. 2020 Nov;35(11):2143-2150. doi: 10.1002/jbmr.4127. Epub 2020 Sep 9. J Bone Miner Res. 2020. PMID: 32909307 Free PMC article.
-
Epidemiology of osteoporosis.Curr Rheumatol Rep. 2006 Feb;8(1):76-83. doi: 10.1007/s11926-006-0030-6. Curr Rheumatol Rep. 2006. PMID: 16515770 Review.
-
Changes in bone mineral density in the hip and spine before, during, and after the menopause in elite runners.Osteoporos Int. 2003 Jul;14(6):462-8. doi: 10.1007/s00198-003-1376-5. Epub 2003 Apr 25. Osteoporos Int. 2003. PMID: 12730740
-
Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels--an observational study during clinical practice conditions.Osteoporos Int. 2011 Jan;22(1):231-40. doi: 10.1007/s00198-010-1214-5. Epub 2010 Jun 17. Osteoporos Int. 2011. PMID: 20556359 Clinical Trial.
-
Molecular backgrounds of age-related osteoporosis from mouse genetics approaches.Rev Endocr Metab Disord. 2006 Jun;7(1-2):17-22. doi: 10.1007/s11154-006-9011-3. Rev Endocr Metab Disord. 2006. PMID: 17123175 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical